Stock BSLN BASILEA PHARMACEUTICA AG
Add to a list
To use this feature you must be a member
Log inSign up

Revisions Basilea Pharmaceutica AG

Equities

BSLN

CH0011432447

Delayed Swiss Exchange
Other stock markets
 03:00:15 2024-07-12 am EDT 		5-day change 1st Jan Change
40.6 CHF -1.34% Intraday chart for Basilea Pharmaceutica AG +2.27% +15.01%
Jun. 20 Basilea Pharmaceutica to Sell Brain Cancer Drug Candidate to US-based Nonprofit MT
Jun. 20 Basilea partners oncology drug candidate lisavanbulin with Glioblastoma Foundation DJ

Turnover - Change in analysts' estimates

Earnings Per Share (EPS) - Change in analysts' estimates

EBIT - Change in analysts' estimates

Dividend / Share (DPS) - Change in analysts' estimates

Cash or Net Debt - Change in analysts' estimates

Turnover

Earnings Per Share (EPS)

EBIT

Dividend / Share (DPS)

Cash or Net Debt

  1. Stock Market
  2. Equities
  3. BSLN Stock
  4. Revisions Basilea Pharmaceutica AG